NIH awards more contracts to develop new testing technologies
tjordan_drupal
Oct 7, 2020
The National Institutes of Health’s Rapid Acceleration of Diagnostics initiative yesterday awarded $98.4 million in contracts to scale up and manufacture new COVID-19 testing technologies.
“The current round of awards support five technologies that can be delivered to the point of care and a powerful laboratory test,” said Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering. “The technologies include an antigen test that provides results in 15 minutes, a viral RNA test deployed in mobile vans that can travel to COVID hotspots and tests that require only saliva, nasal swabs or blood from a finger prick.”
NIH awards more contracts to develop new testing technologies
tjordan_drupal
Oct 7, 2020
The National Institutes of Health’s Rapid Acceleration of Diagnostics initiative yesterday awarded $98.4 million in contracts to scale up and manufacture new COVID-19 testing technologies.
“The current round of awards support five technologies that can be delivered to the point of care and a powerful laboratory test,” said Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering. “The technologies include an antigen test that provides results in 15 minutes, a viral RNA test deployed in mobile vans that can travel to COVID hotspots and tests that require only saliva, nasal swabs or blood from a finger prick.”
Novel Coronavirus (COVID-19)
Headline
